Treatment Response to Hydroxychloroquine, Lopinavir–Ritonavir, and Antibiotics for Moderate COVID-19: A First Report on the Pharmacological Outcomes from South Korea
- DOI
- 10.1101/2020.05.13.20094193
- Published
- 2020-05-18
- Container
- Not recorded
- Publisher
- openRxiv
- Open access
- unknown
Credibility signals
serious concern Score 25/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- serious concernRetraction Watch retraction: 1 retraction notice matched this DOI.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- cautionPublication version: Identified as a preprint; peer review and later versions may change the record.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1101/2020.05.13.20094193,
title = {Treatment Response to Hydroxychloroquine, Lopinavir–Ritonavir, and Antibiotics for Moderate COVID-19: A First Report on the Pharmacological Outcomes from South Korea},
author = {Min Seo Kim and Soon-Woo Jang and Yu-Kyung Park and Bong-Ok Kim and Tae-Ho Hwang and Seok Ho Kang and Won Jun Kim and Park Sung Kyu and Hea-Woon Park and Wonjong Yang and Joonyoung Jang and Min Ho An},
year = {2020},
doi = {10.1101/2020.05.13.20094193},
url = {https://doi.org/10.1101/2020.05.13.20094193}
}RIS
TY - JOUR TI - Treatment Response to Hydroxychloroquine, Lopinavir–Ritonavir, and Antibiotics for Moderate COVID-19: A First Report on the Pharmacological Outcomes from South Korea AU - Min Seo Kim AU - Soon-Woo Jang AU - Yu-Kyung Park AU - Bong-Ok Kim AU - Tae-Ho Hwang AU - Seok Ho Kang AU - Won Jun Kim AU - Park Sung Kyu AU - Hea-Woon Park AU - Wonjong Yang AU - Joonyoung Jang AU - Min Ho An PY - 2020 DO - 10.1101/2020.05.13.20094193 UR - https://doi.org/10.1101/2020.05.13.20094193 ER -
APA
Kim, M. S., Jang, S., Park, Y., Kim, B., Hwang, T., Kang, S. H., Kim, W. J., Kyu, P. S., Park, H., Yang, W., Jang, J., & An, M. H. (2020). Treatment Response to Hydroxychloroquine, Lopinavir–Ritonavir, and Antibiotics for Moderate COVID-19: A First Report on the Pharmacological Outcomes from South Korea. https://doi.org/10.1101/2020.05.13.20094193
Source records
- crossref · retrieved 2026-09-25T19:05:48.036Z